(Q44811212)

6 December 2017

title

Psoriasiform eruption triggered by a dipeptidyl peptidase IV inhibitor (English)

1 reference

6 December 2017

Jorge Santos-Juanes

2

1 reference

ORCID Public Data File 2021

author name string

Albert Mas-Vidal

1

1 reference

6 December 2017

Altea Esteve-Martinez

3

1 reference

6 December 2017

Luis Caminal-Montero

4

1 reference

6 December 2017

Pablo Coto-Segura

5

1 reference

6 December 2017

publication date

13 June 2011

1 reference

Australasian Journal of Dermatology

6 December 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

6 December 2017

volume

53

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

70-72

1 reference

Psoriasis--epidemiology and clinical spectrum

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2011.00783.X

Pathogenesis and clinical features of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2011.00783.X

Sitagliptin: a novel drug for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2011.00783.X

Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2011.00783.X

Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2011.00783.X

CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2011.00783.X

Pilot trial: Pioglitazone versus placebo in patients with plaque psoriasis (the P6).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2011.00783.X

Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2011.00783.X

Inhibitors of dipeptidyl peptidase IV and aminopeptidase N target major pathogenetic steps in acne initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2011.00783.X

Pattern analysis of drug-induced skin diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-0960.2011.00783.X

10.1111/J.1440-0960.2011.00783.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference